These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 34615608)

  • 1. Relation of Left Ventricular Assist Device Infections With Cardiac Transplant Outcomes.
    Parikh A; Halista M; Raymond S; Feinman J; Mancini D; Mitter S; Barghash M; Trivieri M; Contreras J; Taimur S; Roldan J; Murphy J; Pawale A; Anyanwu A; Moss N; Lala A; Pinney S
    Am J Cardiol; 2021 Dec; 160():67-74. PubMed ID: 34615608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors and Clinical Outcomes of Vasoplegia in Patients Bridged to Heart Transplantation With Continuous-Flow Left Ventricular Assist Devices.
    Asleh R; Alnsasra H; Daly RC; Schettle SD; Briasoulis A; Taher R; Dunlay SM; Stulak JM; Behfar A; Pereira NL; Frantz RP; Edwards BS; Clavell AL; Kushwaha SS
    J Am Heart Assoc; 2019 Nov; 8(22):e013108. PubMed ID: 31701791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of infection among left ventricular assist device recipients on post-transplantation outcomes: A retrospective review.
    Lerman DT; Hamilton KW; Byrne D; Lee DF; Zeitler K; Claridge T; Gray J; Minamoto GY
    Transpl Infect Dis; 2018 Dec; 20(6):e12995. PubMed ID: 30199584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vasoplegia after implantation of a continuous flow left ventricular assist device: incidence, outcomes and predictors.
    de Waal EEC; van Zaane B; van der Schoot MM; Huisman A; Ramjankhan F; van Klei WA; Marczin N
    BMC Anesthesiol; 2018 Dec; 18(1):185. PubMed ID: 30526494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of left ventricular assist device (HeartMate II): a Singapore experience.
    Lim CP; Sivathasan C; Tan TE; Lim CH; Kerk KL; Sim DK
    Artif Organs; 2014 Jul; 38(7):543-8. PubMed ID: 24392937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pre-operative risk factors and clinical outcomes associated with vasoplegia in recipients of orthotopic heart transplantation in the contemporary era.
    Patarroyo M; Simbaqueba C; Shrestha K; Starling RC; Smedira N; Tang WH; Taylor DO
    J Heart Lung Transplant; 2012 Mar; 31(3):282-7. PubMed ID: 22112993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence and Impact of On-Cardiopulmonary Bypass Vasoplegia During Heart Transplantation.
    Truby LK; Takeda K; Farr M; Beck J; Yuzefpolskaya M; Colombo PC; Topkara VK; Mancini D; Naka Y; Takayama H
    ASAIO J; 2018; 64(1):43-51. PubMed ID: 28777136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Bridge to Transplantation With Continuous-Flow Left Ventricular Assist Devices on Posttransplantation Mortality.
    Truby LK; Farr MA; Garan AR; Givens R; Restaino SW; Latif F; Takayama H; Naka Y; Takeda K; Topkara VK
    Circulation; 2019 Aug; 140(6):459-469. PubMed ID: 31203669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between continuous-flow left ventricular assist device infections requiring long-term antibiotic use and post-heart transplant morbidity and mortality.
    Lambadaris M; Vishram-Nielsen JKK; Amadio JM; Husain S; Rao V; Billia F; Alba AC
    J Card Surg; 2022 Jan; 37(1):96-104. PubMed ID: 34651943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of severe primary graft dysfunction in patients bridged to heart transplantation with continuous-flow left ventricular assist devices.
    Truby LK; Takeda K; Topkara VK; Takayama H; Garan AR; Yuzefpolskaya M; Colombo P; Naka Y; Farr M
    J Heart Lung Transplant; 2018 Dec; 37(12):1433-1442. PubMed ID: 30206023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Pretransplant Continuous-Flow Left Ventricular Assist Devices on Cellular and Antibody-Mediated Rejection and Subsequent Allograft Outcomes.
    Nestorovic EM; Grupper A; Joyce LD; Milic NM; Stulak JM; Edwards BS; Pereira NL; Daly RC; Kushwaha SS
    Am J Cardiol; 2017 Feb; 119(3):452-456. PubMed ID: 27939231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of Renal Dysfunction Following Heart Transplantation in Patients Bridged with a Left Ventricular Assist Device.
    Tibrewala A; Khush KK; Cherikh WS; Foutz J; Stehlik J; Rich JD
    ASAIO J; 2022 May; 68(5):646-653. PubMed ID: 34419984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes after heart transplantation in sensitized patients bridged with ventricular assist devices.
    Fraser CD; Zhou X; Magruder JT; Suarez-Pierre A; Lui C; Grimm JC; Higgins R; Kilic A
    J Card Surg; 2019 Jun; 34(6):474-481. PubMed ID: 31045281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcome of cardiac transplantation in patients requiring prolonged continuous-flow left ventricular assist device support.
    Takeda K; Takayama H; Kalesan B; Uriel N; Colombo PC; Jorde UP; Yuzefpolskaya M; Mancini DM; Naka Y
    J Heart Lung Transplant; 2015 Jan; 34(1):89-99. PubMed ID: 25444372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Redo sternotomy versus left ventricular assist device explant as risk factors for early mortality following heart transplantation.
    Ribeiro RVP; Alvarez JS; Fukunaga N; Yu F; Adamson MB; Foroutan F; Cusimano RJ; Yau T; Ross H; Alba AC; Billia F; Badiwala MV; Rao V
    Interact Cardiovasc Thorac Surg; 2020 Nov; 31(5):603-610. PubMed ID: 33137824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Institutional volume of heart transplantation with left ventricular assist device explantation influences graft survival.
    Haglund NA; Feurer ID; Ahmad RM; DiSalvo TG; Lenihan DJ; Keebler ME; Schlendorf KH; Stulak JM; Wigger MA; Maltais S
    J Heart Lung Transplant; 2014 Sep; 33(9):931-6. PubMed ID: 24925183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunologic effects of continuous-flow left ventricular assist devices before and after heart transplant.
    Ko BS; Drakos S; Kfoury AG; Hurst D; Stoddard GJ; Willis CA; Delgado JC; Hammond EH; Gilbert EM; Alharethi R; Revelo MP; Nativi-Nicolau J; Reid BB; McKellar SH; Wever-Pinzon O; Miller DV; Eckels DD; Fang JC; Selzman CH; Stehlik J;
    J Heart Lung Transplant; 2016 Aug; 35(8):1024-30. PubMed ID: 27316382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post-cardiac transplant survival after support with a continuous-flow left ventricular assist device: impact of duration of left ventricular assist device support and other variables.
    John R; Pagani FD; Naka Y; Boyle A; Conte JV; Russell SD; Klodell CT; Milano CA; Rogers J; Farrar DJ; Frazier OH
    J Thorac Cardiovasc Surg; 2010 Jul; 140(1):174-81. PubMed ID: 20447659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Left Ventricular Assist Device Exchange on Outcomes After Heart Transplantation.
    Suarez-Pierre A; Zhou X; Lui C; Grimm JC; Hsu S; Choi CW; Kilic A
    Ann Thorac Surg; 2020 Jan; 109(1):78-84. PubMed ID: 31279791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of donor variables on heart transplantation outcomes in mechanically bridged versus standard recipients†.
    Urban M; Booth K; Jungschleger J; Netuka I; Schueler S; MacGowan G
    Interact Cardiovasc Thorac Surg; 2019 Mar; 28(3):455-464. PubMed ID: 30169835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.